We are live on
!
Find out more
CA
Claris Advisors Portfolio holdings
AUM
$383M
1-Year Est. Return
27.62%
This Fund
S&P 500
This Quarter
Est. Return
+6.78%
1 Year Est. Return
+27.62%
3 Year Est. Return
+65.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$36.5M
(+19%)
Cap. Flow
+$22.7M
Cap. Flow
% of AUM
9.86%
Top 10 Holdings %
Top 10 Hldgs %
74.6%
Holding
1,236
New
1,180
Increased
40
Reduced
6
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$1.99M |
| 2 |
EA Bridgeway Omni Small-Cap Value ETF
BSVO
|
+$1.58M |
| 3 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
+$1.23M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$984K |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$833K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caleres
CAL
|
+$443K |
| 2 |
Dimensional US Core Equity Market ETF
DFAU
|
+$94.3K |
| 3 |
Meta Platforms (Facebook)
META
|
+$60.2K |
| 4 |
Cigna
CI
|
+$17.6K |
| 5 |
Lowe's Companies
LOW
|
+$2.66K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 1.91% |
| 2 | Technology | 1.89% |
| 3 | Industrials | 1.6% |
| 4 | Healthcare | 1.33% |
| 5 | Consumer Discretionary | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
TG Therapeutics
TGTX
$8.57B
| $9.94K | ﹤0.01% |
+425
| New | +$9.28K |
|
227
Annaly Capital Management
NLY
$17B
| $9.87K | ﹤0.01% |
+492
| New | +$9.85K |
|
228
Dominion Energy
D
$62.2B
| $9.76K | ﹤0.01% |
+169
| New | +$9.23K |
|
229
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
| $9.62K | ﹤0.01% |
+145
| New | +$9.38K |
|
|
WBA
230
DELISTED
Walgreens Boots Alliance
WBA
| $9.49K | ﹤0.01% |
+1,059
| New | +$10.9K |
|
231
Booking.com
BKNG
$143B
| $8.42K | ﹤0.01% |
+50
| New | +$7.67K |
|
232
IBM
IBM
$205B
| $8.4K | ﹤0.01% |
+38
| New | +$7.45K |
|
233
GE Aerospace
GE
$372B
| $8.3K | ﹤0.01% |
+44
| New | +$7.46K |
|
234
Fidelity Small-Mid Multifactor ETF
FSMD
$2.51B
| $8.28K | ﹤0.01% |
+200
| New | +$7.93K |
|
235
Garrett Motion
GTX
$5.71B
| $8.28K | ﹤0.01% |
+1,012
| New | +$8.51K |
|
|
CXH
236
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $8.14K | ﹤0.01% |
+990
| New | +$7.99K |
|
237
Xylem
XYL
$28.7B
| $8.1K | ﹤0.01% |
+60
| New | +$8.03K |
|
238
Marvell Technology
MRVL
$169B
| $8.08K | ﹤0.01% |
+112
| New | +$7.74K |
|
239
Palantir
PLTR
$306B
| $8K | ﹤0.01% |
+215
| New | +$6.6K |
|
240
Progressive
PGR
$125B
| $7.87K | ﹤0.01% |
+31
| New | +$7.21K |
|
241
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $7.7K | ﹤0.01% |
+765
| New | +$7.54K |
|
242
Acadia Pharmaceuticals
ACAD
$4.34B
| $7.69K | ﹤0.01% |
+500
| New | +$8.34K |
|
243
Eaton
ETN
$152B
| $7.62K | ﹤0.01% |
+23
| New | +$7.03K |
|
244
Manulife Financial
MFC
$73.2B
| $7.39K | ﹤0.01% |
+250
| New | +$6.72K |
|
245
iShares Select Dividend ETF
DVY
$23.8B
| $7.29K | ﹤0.01% |
+54
| New | +$6.98K |
|
246
Eastman Chemical
EMN
$7.81B
| $6.94K | ﹤0.01% |
+62
| New | +$6.2K |
|
247
O'Reilly Automotive
ORLY
$74.8B
| $6.91K | ﹤0.01% |
+90
| New | +$6.61K |
|
248
Agilent Technologies
A
$39.1B
| $6.83K | ﹤0.01% |
+46
| New | +$6.3K |
|
249
Vanguard Mid-Cap Value ETF
VOE
$23.8B
| $6.71K | ﹤0.01% |
+40
| New | +$6.36K |
|
250
ASML
ASML
$632B
| $6.67K | ﹤0.01% |
+8
| New | +$7.15K |
|
Similar funds
MVP
RC
DSA
LWM
RSS
DR
DFA
STP
Claris Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Claris Advisors held 1,236 positions worth $231M, up 19% from $194M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Claris Advisors deployed $22.7M of net new capital in Q3 2024, opening 1,180 new positions and adding to 40 existing holdings. Its largest new stake was Eli Lilly: 665 shares worth $589K.
By sector, the portfolio is most concentrated in Financials at 1.9% of assets, up from 1.3% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Dimensional US Core Equity Market ETF, an estimated $94.3K trimmed.
- Claris Advisors's largest Q3 2024 buy was Eli Lilly: 665 shares worth $589K.
- Claris Advisors added most to Dimensional US Core Equity 2 ETF in Q3 2024, an estimated $1.99M increase.
- Claris Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $94.3K.
- Claris Advisors fully exited Caleres in Q3 2024, selling an estimated $443K.
- Claris Advisors's ten largest holdings make up 75% of its $231M portfolio in Q3 2024.
- Claris Advisors opened 1,180 new positions and closed 1 in Q3 2024.
- Claris Advisors's portfolio value rose 19% quarter-over-quarter to $231M.
Based on Claris Advisors's 13F filing for Q3 2024, filed 31 Oct 2024.